US Patent Issued to FRED HUTCHINSON CANCER CENTER, JUNO THERAPEUTICS on April 7 for "T cell receptors specific for mesothelin and their use in immunotherapy" (Washington Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,290, issued on April 7, was assigned to FRED HUTCHINSON CANCER CENTER (Seattle) and JUNO THERAPEUTICS INC. (Seattle).

"T cell receptors specific for mesothelin and their use in immunotherapy" was invented by Thomas M. Schmitt (Seattle), Aude G. Chapuis (Seattle) and Philip D. Greenberg (Mercer Island, Wash.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Binding proteins specific for Msln20-28 or Msln530-538 peptides are provided herein. Polynucleotides encoding the binding proteins, as well as compositions and recombinant host cells comprising the binding proteins or polynucleotides are also provided. The compositions and recombinant host cells may ...